| Literature DB >> 33489681 |
Neha Gupta1, Sameer Suresh Bhagyawant1.
Abstract
Chickpea seed proteins are alleged source of nutraceuticals. These seed proteins were subjected to different proteases to produce peptides. The efficacy of these peptides was confirmed using six diverse human cancer cell lines (PA-1, Ishikawa cells, A549, MCF-7, HepG2, MDA-MB-231). Alcalase generated peptides exhibited the highest antagonistic inhibition of Ishikawa cells. Flow cytometric analysis revealed that chickpea peptide induced S and G2 phase arrest of cell cycle in a dose dependent manner. DNA fragmentation and apoptosis occurred by down regulation of Bcl-2 expression, upregulation of Bax expression and promotion of caspase-3 initiation. Chickpea peptides ascertain potential antiproliferative molecule that can be deployed in cancer treatment regimes. © King Abdulaziz City for Science and Technology 2021.Entities:
Keywords: Alcalase; Bioactive; Chickpea peptide; Human cancer cells
Year: 2021 PMID: 33489681 PMCID: PMC7803852 DOI: 10.1007/s13205-020-02614-6
Source DB: PubMed Journal: 3 Biotech ISSN: 2190-5738 Impact factor: 2.406